IRTC

Irhythm Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 1/10
Irhythm Holdings sales and earnings growth
IRTC Growth
Good
  • Revenue Y/Y↑ 27.36%
  • EPS Y/Y↑ 72.93%
  • FCF Y/Y↑ 34.50%
Irhythm Holdings gross and profit margin trends
IRTC Profitability
Neutral
  • Gross margin ↑ 71.00%
  • EPS margin↓ -3.50%
  • ROIC 5Y↓ -13.47%
Irhythm Holdings net debt vs free cash flow
IRTC Risk
Poor
  • Debt / Equity↑ 4.5
  • Debt / FCF↑ 25.6
  • Interest coverage↓ -1.0

Irhythm Holdings stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

↗ More Medical Devices stocks